Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.
Having just one dose of the COVID-19 vaccine significantly reduced multiple psychological distress factors, improving the well-being and safety of recipients.